G1 kinases and transforming growth factor-β signaling are associated with a growth pattern switch in diabetes-induced renal growth

Kidney International

Volumn 58, Issue 1, 2000, Pages 162-172

  Huang, Hai Chang ^a   Preisig, Patricia A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cell cycle dependent hypertrophy; Hyperplasia; Nephromegaly; Proximal renal tubule; Renal hypertrophy; Smad proteins

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIN D; CYCLIN E; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; CDK2 PROTEIN, RAT; CDK4 PROTEIN, RAT; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E DEPENDENT KINASE; CYCLIN E-DEPENDENT KINASE; DNA BINDING PROTEIN; MADH2 PROTEIN, RAT; MADH4 PROTEIN, RAT; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; HYPERPLASIA; KIDNEY DEVELOPMENT; KIDNEY SIZE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL CYCLE G1 PHASE; CHEMISTRY; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; HYPERTROPHY; KIDNEY PROXIMAL TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DNA-BINDING PROTEINS; G1 PHASE; HYPERPLASIA; HYPERTROPHY; KIDNEY TUBULES, PROXIMAL; MALE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033623783     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00151.x     Document Type: Article

References (30)

1. 1. IBRAHIM HN, HOSTETTER TH: Diabetic nephropathy. J Am Soc Nephrol 8:487-493, 1997
2. 2. SEYER-HANSEN K: Renal hypertrophy in experimental diabetes mellitus. Kidney Int 23:643-646, 1983
3. 3. SEYER-HANSEN K: Renal hypertrophy in experimental diabetes: A comparison to compensatory hypertrophy. Diabetologia 14:325-328, 1978
4. 4. SEYER-HANSEN K: Renal hypertrophy in experimental diabetes: Relation to severity of diabetes. Diabetologia 13:141-143, 1977
5. 5. SEYER-HANSEN K: Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 51:551-555, 1976
6. 6. SEYER-HANSEN K, HANSEN J, GUNDERSON HJG: Renal hypertrophy in experimental diabetes. Diabetologia 18:501-505, 1980
7. 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia 25:280-287, 1983
8. 4Cl-induced hypertrophy is mediated by weak base effects and is independent of cell cycle processes. Am J Physiol 270:C932-C938, 1996
9. 9. FRANCH HA, SHAY JW, ALPERN RJ, PREISIG PA: Involvement of pRB family in TGFβ-dependent epithelial cell hypertrophy. J Cell Biol 129:245-254, 1995
10. 10. LIU B, PREISIG PA: TGFβ-mediated hypertrophy in rat renal epithelial cells involves inhibiting pRB phosphorylation by preventing activation of cdk2/cyclin E kinase. Am J Physiol 277:F186-F194, 1999
11. 11. PREISIG PA: Renal hypertrophy and hyperplasia, in The Kidney: Physiology and Pathophysiology, edited by SELDEN DW, GIEBISCH G, Philadelphia: Lippincott, Williams & Wilkins (in press)
12. 12. PREISIG PA: What makes cells grow larger and how do they do it: Hypertrophy revisited. Exp Nephrol 7:273-283, 1999
13. 13. PREISIG PA, FRANCH HA: Renal epithelial cell hyperplasia and hypertrophy. Semin Nephrol 15:327-340, 1995
14. 14. KITAGAWA M, HIGASHI H, JUNG H-K, SUZUKI-TAKAHASHI I, IKEDA M, TAMAI K, KATO J, SEGAWA K, YOSHIDA E, NISHIMURA S, TAYA Y: The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 15:7060-7069, 1997
15. 15. LUNDBERG AS, WEINBERG RA: Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753-761, 1998
16. 16. WEINTRAUB SJ, PRATER CA, DEAN DC: Retinoblastoma protein switches the E2F site from a positive to negative element. Nature 358:259-261, 1992
17. 17. WOLF G, ZIYADEH FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56:393-405, 1999
18. 18. ABBOUD HE: Growth factors and diabetic nephropathy: An overview. Kidney Int 52:S3-S6, 1997
19. 19. PARK IN, KIYOMOTO H, ABBOUD SL, ABBOUD HE: Expression of transforming growth factor-B and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
20. 20. ZIYADEH FN, HAN DC: Involvement of transforming growth factor-β and its receptors in the pathogenesis of diabetic nephropathy. Kidney Int 51(Suppl 60):S7-S11, 1997
21. 23Na NMR spectroscopy of proximal tubule suspensions. Kidney Int 29:747-751, 1986
22. 22. SCHAEFER L, SCHAEFER RM, TESCHNER M, HEIDLAND A: Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 37:567-571, 1994
23. 23. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
24. 24. LABARCA C, PAIGEN K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352, 1980
25. WAF1,CIP1 is increased in experimental diabetic nephropathy: Potential role in glomerular hypertrophy. J Am Soc Nephrol 9:986-993, 1998
26. Kip1 in cultured mouse mesangial cells: Relationship to hypertrophy. Am J Physiol 42:F348-F356, 1997
27. Kip1 in diabetic db/db mouse: Role of hyperglycemia. Kidney Int 53:869-879, 1998
28. 28. PETERS H, NOBLE NA, BORDER WA: Transforming growth factor-β in human glomerular injury. Curr Opin Nephrol Hypertens 6:389-393, 1997
29. 29. SATO H, IWANO M, AKAI Y, KURIOKA H, KUBO A, YAMAGUCHI T, HIRATA E, KANAUCHI M, DOHI K: Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am J Nephrol 18:490-494, 1988
30. 30. SHARMA K, JIN Y, GUO J, ZIYADEH FN: Neutralization of TGFβ by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996